XML 28 R19.htm IDEA: XBRL DOCUMENT
v3.23.3

EARNINGS PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
EARNINGS PER SHARE | EARNINGS PER SHARE The following is a reconciliation of basic common shares outstanding to diluted common and common equivalent shares outstanding:
| Fiscal quarter ended |  | Three fiscal quarters ended
| September 30, 2023 |  | October 1, 2022 |  | September 30, 2023 |  | October 1, 2022
Weighted-average number of common and common equivalent shares outstanding: |  |  |  |  |  |  |
Basic number of common shares outstanding | 36,438,403 |  |  | 38,222,151 |  |  | 36,789,140 |  |  | 39,279,293 |
Dilutive effect of equity awards | 3,881 |  |  | 23,222 |  |  | 3,781 |  |  | 34,835 |
Diluted number of common and common equivalent shares outstanding | 36,442,284 |  |  | 38,245,373 |  |  | 36,792,921 |  |  | 39,314,128 |
Earnings per share: |  |  |  |  |  |  |
(dollars in thousands, except per share data) |  |  |  |  |  |  |
Basic net income per common share: |  |  |  |  |  |  |
Net income | $ | 66,127 |  |  | $ | 64,957 |  |  | $ | 125,990 |  |  | $ | 169,859 |
Income allocated to participating securities | (1,267) |  |  | (1,013) |  |  | (2,254) |  |  | (2,478) |
Net income available to common shareholders | $ | 64,860 |  |  | $ | 63,944 |  |  | $ | 123,736 |  |  | $ | 167,381 |
Basic net income per common share | $ | 1.78 |  |  | $ | 1.67 |  |  | $ | 3.36 |  |  | $ | 4.26 |
Diluted net income per common share: |  |  |  |  |  |  |
Net income | $ | 66,127 |  |  | $ | 64,957 |  |  | $ | 125,990 |  |  | $ | 169,859 |
Income allocated to participating securities | (1,267) |  |  | (1,012) |  |  | (2,254) |  |  | (2,477) |
Net income available to common shareholders | $ | 64,860 |  |  | $ | 63,945 |  |  | $ | 123,736 |  |  | $ | 167,382 |
Diluted net income per common share | $ | 1.78 |  |  | $ | 1.67 |  |  | $ | 3.36 |  |  | $ | 4.26 |
Anti-dilutive awards excluded from diluted earnings per share computation(*) | 460,947 |  |  | 525,349 |  |  | 483,921 |  |  | 465,529
(*)The volume of anti-dilutive awards is, in part, due to the related unamortized compensation costs.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration